SLSSELLAS Life Sciences Group, Inc.

$13.73

Who owns SLS

159 institutions reported holding SLS for 2026Q1, together 31% of the company, more than the 111 a quarter earlier.

159

Institutions reporting a position · as of 2026Q1 · up from 111 the quarter before

Shares held by institutions
54.0M

Shares held by institutions · 31% of the company · long US equity positions only, as reported on Form 13F

Reported value
$228M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
21%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
33
New positions
62
Positions exited
17
Added to
53
Reduced
17
Top 10 holdersof the company
25%
Institutional ownership by quarter, 2018Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q115954.0M$228M
2025Q411135.4M$134M
2025Q39332.9M$53M
2025Q27826.8M$59M
2025Q14514.3M$15M
2024Q4306.2M$6.4M
2024Q3325.4M$6.7M
2024Q2294.1M$4.8M
2024Q1297.7M$7.8M
2023Q4303.5M$3.7M
2023Q3272.8M$4.5M
2023Q2243.1M$4.9M
2023Q1223.0M$4.3M
2022Q4291.9M$4.5M
2022Q3282.2M$4.4M
2022Q2263.0M$6.6M
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.12.2M7.1%$52M
VANGUARD GROUP INC10.3M6.0%$44M
STATE STREET CORP8.4M4.9%$36M
GEODE CAPITAL MANAGEMENT LLC3.9M2.3%$17M
Marshall Wace LLP2.0M1.2%$8.6M
JONES FINANCIAL COMPANIES LLLP1.7M0.97%$7.3M
MORGAN STANLEY1.3M0.78%$5.7M
NORTHERN TRUST CORP1.3M0.74%$5.4M
DAGCO, INC.1.0M0.60%$4.4M
UBS Group AG0.7M0.43%$3.2M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…